Evidence map›Paper›PMID 40060431›Full record

ArticlebioRxiv : the preprint server for biology2025

Detection of PCR chimeras in adaptive immune receptor repertoire sequencing using hidden Markov models.

Mark Chernyshev, Aron Stålmarck, Martin Corcoran, Gunilla B Karlsson Hedestam, Ben Murrell

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Mark ChernyshevDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-1622-9240
Aron StålmarckDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Martin CorcoranDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Gunilla B Karlsson HedestamDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Ben MurrellDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Funding

HIV-1 dynamics and evolution during trispecific broadly neutralizing antibody therapyR01AI157854 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI KURITZKES, DANIEL R., TSIBRIS, ATHE M. · 2021 to 2025
$4.0M
NIAID NIH HHS R01 AI157854
6 · The paper itself

Abstract

Adaptive Immune Receptor Repertoire sequencing (AIRR-seq) has emerged as a central approach for studying T cell and B cell receptor populations, and is now an important component of studies of autoimmunity, immune responses to pathogens, vaccines, allergens, and cancers, and for antibody discovery. When amplifying the rearranged V(D)J genes encoding antigen receptors, each cycle of the Polymerase Chain Reaction (PCR) can produce spurious "chimeric" hybrids of two or more different template sequences. While the generation of chimeras is well understood in bacterial and viral sequencing, and there are dedicated tools to detect such sequences in bacterial and viral datasets, this is not the case for AIRR-seq. Further, the process that results in immune receptor sequences has domain-specific challenges, such as somatic hypermutation (SHM), and domain-specific opportunities, such as relatively well-known germline gene "reference" sequences. Here we describe CHMMAIRRa, a hidden Markov model for detecting chimeric sequences in AIRR-seq data, that specifically models SHM and incorporates germline reference sequences. We use simulations to characterize the performance of CHMMAIRRa and compare it to existing methods from other domains, we test the effect of PCR conditions on chimerism using IgM libraries generated in this study, and we apply CHMMAIRRa to four published AIRR-seq datasets to show the extent and impact of artifactual chimerism.

Indexed as

Chimeric DNA moleculesHMMNext-generation sequencingPCR

Identifiers

PMID40060431
PMCPMC11888211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.